Literature DB >> 17153025

The treatment of vasomotor nonallergic rhinitis.

Michael A Kaliner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17153025

Source DB:  PubMed          Journal:  Clin Allergy Immunol        ISSN： 1075-7910


× No keyword cloud information.
  3 in total

1.  The effects of heated humidifier in continuous positive airway pressure titration.

Authors:  Chung-Chieh Yu; Cheng-Ming Luo; Yu-Chih Liu; Huang-Pin Wu
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

2.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05

3.  Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis.

Authors:  Michael A Kaliner; James N Baraniuk; Michael S Benninger; Jonathan A Bernstein; Phil Lieberman; Eli O Meltzer; Robert M Naclerio; Russell A Settipane; Judith R Farrar
Journal:  World Allergy Organ J       Date:  2009-08-15       Impact factor: 4.084
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.